metsera glp-1 10-K GLP-1-based therapies for diabetes, obesity
Description
Among these patients, 45.2% achieved a dose of 1 mg (injectable), and 14.2% reached 14 mg (oral) [1]
Read our guide to weight loss shots and how they work
doi: 10.1016/S2213-2600(15)00043-0, 4
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
5e), but the sustained increase of [Ca 2+ ] i occurring at the assays end-point was unaffected (Fig
